MaRS Future of Medicine Series - Going public: What you need to know when taking your company to the public markets
Wednesday, December 12, 2012 from 12:00 PM to 1:00 PM (EST)
Join us at an exceptional MaRS Future of Medicine speaker series event on December 12th, as Justin Canivet and Douglas Loe discuss life sciences companies on the public markets. They will provide an overview of the Canadian market, discuss the pathways for life sciences companies going public, address what investors are looking for, and how to value your company.
Both bring great expertise from which attendees will certainly benefit: Justin is the Head of Listings Business Development for the life sciences and diversified industries sectors with Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV), and Douglas is an Analyst, Global Healthcare & Biotechnology with Byron Capital Markets. Don’t miss out!
Part of the MaRS Future of Medicine™ Series
MaRS Future of Medicine™ Series is a must-attend event for anyone engaged in translational research or commercial development within the life sciences.
When & Where
MaRS Discovery District
MaRS (www.marsdd.com) is a large scale, mission driven innovation centre located in Toronto and networked across Ontario, focused on building Canada’s next generation of technology companies.
MaRS works closely with entrepreneurs to grow and scale their ventures into global market leaders in life sciences and health care, information, communications and entertainment technologies, cleantech, advanced materials and engineering, as well as innovative social purpose businesses.